Molecular Biology of Huntington's Disease

被引:0
|
作者
Ersoy, Nagehan [1 ]
Basak, A. Nazli [1 ]
机构
[1] Bogazici Univ, Mol Biyol & Genet Bolumu, TR-34342 Bebek, Turkey
关键词
Huntington's Disease; polyglutamine diseases; CAG repeats; neurodegeneration;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's Disease ( HD) is the most common among nine known polyglutamine disorders. Its prevalence is estimated to be 3-7/100 000 in populations of Western European descent. HD is an autosomal dominantly inherited neurodegenerative disorder of the central nervous system, characterized by involuntary movements, impaired motor coordination, cognitive loss and various psychiatric abnormalities. The most prominent pathological finding is the selective neuron death in basal ganglia. The disease gene ( IT-15), localized to chromosome 4 in 1993 and 180kb long, is composed of 67 exons. The gene product is a 348 kDa protein, called huntingtin, whose function is not known yet. The mutation causing HD is the expansion of the CAG triplet repeat in the first exon of the IT-15 gene. Huntington's Disease Working Group has identified four repeat intervals: People who carry 26 or less CAG repeats in the IT-15 gene are healthy, alleles with 27-35 repeats may show intergenerational instability, people carrying 36-39 CAG repeats may or may not develop the disease, however 40 or more CAG repeats definitely cause HD, if people live long enough. The molecular diagnosis of HD with direct mutation analysis has been available since 1993. In this method, the CAG repeat region on the IT15 gene is PCR-amplified, and the repeat number is determined using radioactive
引用
收藏
页码:27 / 44
页数:16
相关论文
共 50 条
  • [31] Huntington's disease: A molecular genetic and CT comparison
    Sharma, P
    Savy, L
    Britton, J
    Taylor, R
    Howick, A
    Patton, M
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02): : 206 - 208
  • [32] Huntington's Disease: Cellular and Molecular Basis of Pathology
    Korzhova, V. V.
    Artamonov, D. N.
    Vlasova, O. L.
    Bezprozvanny, I. B.
    [J]. ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2014, 64 (04) : 359 - 375
  • [33] Molecular medicine: predicting and preventing Huntington’s disease
    Ferdinando Squitieri
    Milena Cannella
    Luigi Frati
    [J]. Neurological Sciences, 2008, 29 : 205 - 207
  • [34] Molecular analysis of Huntington's disease in a Cuban population
    Vazquez-Mojena, Y.
    Laffita-Mesa, J. M.
    Laguna-Salvia, L.
    Gonzalez-Zaldivar, Y.
    Almaguer-Gotay, D.
    Zayas-Feria, P.
    Almaguer-Mederos, L. E.
    Rodriguez-Labrada, R.
    Velazquez-Perez, L.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S61 - S61
  • [35] A molecular investigation of true dominance in Huntington's disease
    Narain, Y
    Wyttenbach, A
    Rankin, J
    Furlong, RA
    Rubinsztein, DC
    [J]. JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) : 739 - 746
  • [36] Molecular medicine: predicting and preventing Huntington's disease
    Squitieri, Ferdinando
    Cannella, Milena
    Frati, Luigi
    [J]. NEUROLOGICAL SCIENCES, 2008, 29 (04) : 205 - 207
  • [37] Molecular diagnosis Approch for Huntington's Disease in Tunisia
    Nehdi, H.
    Chebbi, E.
    Nabli, F.
    Saied, Z.
    Ben Sassi, S.
    Amouri, R.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S7 - S7
  • [38] Molecular approaches to dissecting the pathogenesis of Huntington's disease
    Muchowski, P.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 : A6 - A6
  • [39] Mapping molecular changes in Huntington's disease brain
    Stoy, N.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 : A4 - A4
  • [40] Huntington's disease: From morphology to molecular neuropathology
    Pluot, M
    [J]. SEMAINE DES HOPITAUX, 1997, 73 (15-16): : 487 - 491